ARPU

With profits rebounding and a major acquisition secured, GTPL Hathway's Q1 results signal a bold new phase of strategic expansion and technological ambition.

As Reddit prepares its Q2 2026 report, all eyes are on whether its explosive user growth and unique community can sustain its post-IPO financial success.

TextMagic's Q2 results reveal a counterintuitive strategy: shedding users while growing revenue. Is this disciplined pivot to high-value clients a masterstroke?

The battle for your living room is no longer just about speed. A new deal in Florida shows how ISPs are bundling streaming to lock in loyalty and revenue.

Huawei's new strategy shifts telecom revenue from data volume to AI service consumption. A deep dive into the 'token economy' and the network overhaul it demands.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

Soaring healthcare costs, fueled by GLP-1 drugs, have employers trapped. A new report shows why flexible benefits are becoming a critical survival strategy.

New research reveals Indigenous-led projects are not just a social good, but a critical economic engine for Canada's energy transition and resource economy.

As National Outlet Shopping Day returns, it's more than a sale. It's Simon's blueprint for the future of retail and a key test of consumer spending.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

As SpaceX targets a historic IPO, its rockets are overshadowed. Starlink's satellite internet is now the sole profit engine, forcing a radical re-evaluation.

Kuaishou's Q1 results show its AI platform Kling is a breakout hit, but declining profits and live streaming revenue raise questions about its costly pivot.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Moving beyond advice, Rain's new AI financial agent takes action to stabilize cash flow and build wealth, but it raises new questions about trust.

For the fifth time, Republic Services is one of Fortune's 'Most Admired.' An inside look at the strategy of ethics, innovation, and culture driving its success.